Buscar
01/02/2026
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry
López-López, C, de Castro, EM, Montes, AF, Orozco, EJ, Peraita, SL, Vera, R, Cerdá, P, Calvo, M, Paredes, BG, de Mena, ML, La Casta, A, Gallego, J, Adeva, J, Cano, JMC, Ruiz-Casado, A, Vidal-Tocino, R, García-García, T, Pazo-Cid, R, Garrote, MR, Sastre, J. Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry. Clinical & Translational Oncology. 2026; 28(2)DOI:10.1007/s12094-025-04010-z. PMID:40782167. IF:2.500(Q3/6D).
01/02/2026
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial
Molassiotis, A, Jordan, K, Karthaus, M, Dranitsaris, G, Roeland, EJ, Schwartzberg, L, Stimamiglio, V, Alonzi, A, Tilola, SO, Bonizzoni, E, Vázquez, EB, Buchler, T, Cheng, Y, Christoph, DC, Alfonso, PG, Lu, X, Majem, M, Mavroudis, D, Syrigos, K, Tomlins, E, Zhou, Z, Zimovjanová, M, Aapro, M. Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial. ANNALS OF ONCOLOGY. 2026; 37(2)DOI:10.1016/j.annonc.2025.10.017. PMID:41110696. IF:65.400(Q1/1D).
01/02/2026
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
Gonzalez-Cao, M, Berciano-Guerrero, MA, Muñoz-Couselo, E, Manzano, JL, Cerezuela-Fuentes, P, Crespo, G, Soria, A, de Miguel, PA, Sanz, LG, de la Rosa, CA, Castaño, AG, Puértolas, T, Espinosa, E, Medina, J, Bellido, L, Berrocal, A, Majem, M, Castro, RL, Fernandez, LA, Garcia, F, de la Borbolla, MR, Algarra, SM, Márquez-Rodas, I. Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry. Clinical & Translational Oncology. 2026; 28(2)DOI:10.1007/s12094-025-04018-5. PMID:40841506. IF:2.500(Q3/6D).
01/02/2026
Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates
Rueda, A, Garcia-Leon, A, Arena, LA, Mendoza, JI, Avino, A, Fabrega, C, Eritja, R, Paez, D, Alba-Castellon, L, Vazquez, E, Villaverde, A, Mangues, R, Casanova, I, Unzueta, U. Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates. Materials Today Bio. 2026; 36DOI:10.1016/j.mtbio.2025.102698. PMID:41560806. IF:10.200(Q1/1D).